Avanos Medical (AVNS) Short term Debt (2013 - 2026)

Avanos Medical's Short term Debt history runs 9 years deep, the most recent figure standing at $10.9 million for Q1 2026.

• In Q1 2026, Short term Debt rose 15.96% year-over-year to $10.9 million; the TTM figure through Mar 2026 stood at $10.9 million (up 15.96% YoY), while the FY2025 annual figure was $10.2 million, up 8.51% from the prior year.
• Short term Debt came in at $10.9 million for Q1 2026 at Avanos Medical, up from $10.2 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $10.9 million in Q1 2026 to a low of $4.7 million in Q2 2022.
• A 5-year average of $8.2 million and a median of $9.4 million in 2024 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt soared 64.52% in 2024 and fell 7.84% in 2025, its largest moves.
• Avanos Medical's Short term Debt stood at $6.2 million in 2022, then surged by 38.71% to $8.6 million in 2023, then rose by 9.3% to $9.4 million in 2024, then climbed by 8.51% to $10.2 million in 2025, then advanced by 6.86% to $10.9 million in 2026.
• According to Business Quant data, Short term Debt over the past three periods registered $10.9 million, $10.2 million, and $9.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison